Publications

2022

Mimics and Pitfalls of Primary Ovarian Malignancy Imaging

Tomography.8(1):100-119[DOI] 10.3390/tomography8010009.[PMID] 35076619.

3 citations·PubMed·Publisher's Site

2018

Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells.

Clinical cancer research : an official journal of the American Association for Cancer Research.24(19):4874-4886[DOI] 10.1158/1078-0432.CCR-17-3697.[PMID] 29959144.

40 citations·PubMed·Publisher's Site

2016

MAPK Activation Predicts Poor Outcome and the MEK Inhibitor, Selumetinib, Reverses Antiestrogen Resistance in ER-Positive High-Grade Serous Ovarian Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research.22(4):935-47[DOI] 10.1158/1078-0432.CCR-15-0534.[PMID] 26482043.

34 citations·PubMed·Publisher's Site

2012

Significance of lymphovascular space invasion in epithelial ovarian cancer.

Cancer medicine.1(2):156-64[DOI] 10.1002/cam4.31.[PMID] 23342265.

37 citations·PubMed·Publisher's Site

2012

Synchronous of breast and vulvar Paget's disease: a case report.

European journal of gynaecological oncology.33(5):534-6[DOI] .[PMID] 23185806.

4 citations·PubMed·Publisher's Site

2009

Clitoral metastasis of anal adenocarcinoma associated with rectovaginal fistula in long standing Crohn's disease.

European journal of obstetrics, gynecology, and reproductive biology.144(2):182-3[DOI] 10.1016/j.ejogrb.2009.02.042.[PMID] 19406559.

5 citations·PubMed·Publisher's Site

Show More